Explore the Potential with AI-Driven Innovation
The focused library is created on demand with the latest virtual screening and parameter assessment technology, supported by the Receptor.AI drug discovery platform. This method is more effective than traditional methods and results in higher-quality compounds with better activity, selectivity, and safety.
We pick out particular compounds from an extensive virtual database of more than 60 billion molecules. The preparation and shipment of these compounds are facilitated by our associate Reaxense.
Contained in the library are leading modulators, each labelled with 38 ADME-Tox and 32 physicochemical and drug-likeness qualities. In addition, each compound is illustrated with its optimal docking poses, affinity scores, and activity scores, giving a complete picture.
Our high-tech, dedicated method is applied to construct targeted libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
It includes comprehensive molecular simulations of the catalytic and allosteric binding pockets and the ensemble virtual screening accounting for their conformational mobility. In the case of designing modulators, the structural changes induced by reaction intermediates are taken into account to leverage activity and selectivity.
Our library stands out due to several important features:
partner
Reaxense
upacc
Q9BX84
UPID:
TRPM6_HUMAN
Alternative names:
Channel kinase 2; Melastatin-related TRP cation channel 6
Alternative UPACC:
Q9BX84; Q6VPR8; Q6VPR9; Q6VPS0; Q6VPS1; Q6VPS2
Background:
Transient receptor potential cation channel subfamily M member 6, also known as Channel kinase 2 and Melastatin-related TRP cation channel 6, plays a pivotal role in magnesium homeostasis. It is essential for magnesium absorption in the gut and kidney, functioning as both an ion channel and a serine/threonine-protein kinase.
Therapeutic significance:
The protein is directly linked to Hypomagnesemia 1, a disorder characterized by impaired intestinal magnesium absorption leading to severe neurological symptoms. Understanding its mechanism could pave the way for targeted therapies to correct magnesium imbalance.